Advertisement

Somatostatin pp 261-274 | Cite as

Somatostatin Alterations and Brain Diseases

  • J. Epelbaum
  • Y. Agid
  • A. Enjalbert
  • M. Hamon
  • F. Javoy-Agid
  • C. Kordon
  • Y. Lamour
  • E. Moyse
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 188)

Abstract

Soon after its discovery as a hypothalamic growth hormone inhibiting factor, somatostatin-14 (S-14, SRIF) was localized by radioimmunoassay (1, 2) and immunocytochemistry (3–5) in extra-hypothalamic structures. Present in neurons, S-14 is synthesized as part of a prohormone and transported to nerve terminals from which it is released in response to depolarizing stimuli. The peptide is then degraded in situ by enzymes after binding to its specific receptors (6, 7). In the pituitary, S-14 seems to act by inhibiting adenylate cyclase (8–10); but in the brain, its mechanism of action is still poorly understood.

Keywords

Laminar Distribution Cholinergic Marker Choline Acetyl Transferase Human Frontal Cortex Parkinsonian Subject 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brownstein M, Arimura A, Sato H, Kizer JS 1975 The regional distribution of somatostatin in rat brain. Endocrinology 96: 1456.PubMedCrossRefGoogle Scholar
  2. 2.
    Kobayashi RM, Vale M 1977 Regional distribution of neurotensin and somatostatin in rat brain. Brain Res 126: 584.PubMedCrossRefGoogle Scholar
  3. 3.
    Elde R, Hökfelt T 1979 Localization of hypophysiotropic peptides and other biologically active peptides within the brain. Ann Rev Physiol 41: 587.CrossRefGoogle Scholar
  4. 4.
    Bennett-Clark C, Romagnano MA, Joseph SA 1980 Distribution of somatostatin in the rat brain: telencephalon and diencephalon. Brain Res 188: 473.CrossRefGoogle Scholar
  5. 5.
    Finley JCW, Maderdrut JL, Rogers LJ, Petrusz P 1981 The imtnunocytochemical localization of somatostatin-containing neurons in the rat central nervous system. Neuroscience 6: 2173.PubMedCrossRefGoogle Scholar
  6. 6.
    Srikant CB, Patel YC 1981 Somatostatin receptors: identification and characterization in rat brain membranes. Proc Natl Acad Sci 78: 3930.PubMedCrossRefGoogle Scholar
  7. 7.
    Epelbaum J, Tapia Arancibia L, Kordon C, Enjalbert A 1982 Characterization, regional distribution and subcellular distri-bution of [’25I]-Tyr-somatostatin binding sites in rat brain. J Neurochem 38: 1515.PubMedCrossRefGoogle Scholar
  8. 8.
    Rouleau D, Barden N 1981 Inhibition of anterior pituitary prostaglandin stimulated adenylate cyclase activity by somatostatin. Can J Biochem 59: 307.PubMedCrossRefGoogle Scholar
  9. 9.
    Cronin MJ, Rogol AD, Myers GA, Hewlett EL 1983 Pertussis toxin blocks the somatostatin induced inhibition of growth hormone release and adenosine 3’-5’ monophosphate accumulation. Endocrinology 113: 209.PubMedCrossRefGoogle Scholar
  10. 10.
    Koch BD, Schonbrunn A 1984 The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes. Endocrinology 114: 1784.PubMedCrossRefGoogle Scholar
  11. 11.
    Dodd J, Kelly JS 1978 Is somatostatin an excitatory transmitter in the hippocampus? Nature 273: 674.PubMedCrossRefGoogle Scholar
  12. 12.
    Pittman QJ, Siggins GR 1981 Somatostatin hyperpolarizes hippocampal pyramidal cells in vitro. Brain Res 221: 402.PubMedCrossRefGoogle Scholar
  13. 13.
    Epelbaum J, Arancibia S, Drouva SV, Kordon C 1982 Mode et régulation de la sécrétion de la somatostatine cérébrale. In: Tixier Vidal A, Richard P (eds) Régulations Cellulaires Multihormonales en Neuroendocrinologie. INSERM, Paris, 110: 103.Google Scholar
  14. 14.
    Reichlin S 1983 Somatostatin. N Engl J Med 309:1495 (Part I) and (Part 2 ) 1556.PubMedCrossRefGoogle Scholar
  15. 15.
    Patel YC, Rao K, Reichlin S 1977 Somatostatin in human cerebrospinal fluid. N Engl J Med 296: 529.PubMedCrossRefGoogle Scholar
  16. 16.
    Cramer H, Kohler J, Oepen G, Schonberg G, Schroter E 1981 Huntington’s chorea-measurements of somatostatin, substance P, and cyclic nucleotides in the cerebrospinal fluid. J Neurol 225: 183.PubMedCrossRefGoogle Scholar
  17. 17.
    Dupont E, Christensen SE, Hansen AP, Olivarias BF, Orskov H 1982 Low cerebrospinal fluid somatostatin in Parkinson’s disease: an irreversible abnormality. Neurology 32: 312.PubMedCrossRefGoogle Scholar
  18. 18.
    Wood PL, Etienne P, Lal S, Gauthier S, Cajal S, Nair NPV 1982 Reduced lumbar CSF somatostatin levels in Alzheimer’s disease. Life Sci 31: 2073.PubMedCrossRefGoogle Scholar
  19. 19.
    Rubinow DR, Gold PW, Post RM, Ballenger JC, Cowdry R, Bollinger J, Reichlin S 1983 CSF somatostatin in affective illness. Arch Gen Psych 40: 409.CrossRefGoogle Scholar
  20. 20.
    Sorensen KV, Christensen SE, Dupont E, Hansen AP, Pedersen E, Orskov A 1980 Low somatostatin content in cerebrospinal fluid in multiple sclerosis. Acta Neurol Scandinav 61: 186.CrossRefGoogle Scholar
  21. 21.
    Beal NF, Martin JB 1984 Somatostatin: normal and abnormal observations in the central nervous system. In: Wurtman RJ, Corkin SH, Growdow JH (eds) Alzheimer’s Disease: Advances in Basic Research and Therapies. Center for Brain Sciences and Metabolism, Charitable Trust, p 229.Google Scholar
  22. 22.
    Aronin N, Cooper PE, Lorenz LJ, Bird ED, Sagar SM, Leeman SE, Martin JB 1983 Somatostatin is increased in the basal ganglia in Huntington’s disease. Ann Neurol 13: 519.PubMedCrossRefGoogle Scholar
  23. 23.
    Nemeroff CB, Youngblood WW, Manberg, PJ, Prange AJ, Kizer JS 1983 Regional brain concentrations of neuropeptides in Huntington’s chorea and schizophrenia. Science 221: 972.PubMedCrossRefGoogle Scholar
  24. 24.
    Ferrier IW, Roberts GW, Crow TJ, Johnstone EC, Owens DGC, Lee YC, O’Shaughnessy DO, Adrian TE, Polak JM, Bloom SR 1983 Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms - in schizophrenia. Life Sci 33: 475.PubMedCrossRefGoogle Scholar
  25. 25.
    Davies P, Katzman R, Terry RD 1980 Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288: 279.PubMedCrossRefGoogle Scholar
  26. 26.
    Rossor MN, Emson PC, Mountjoy CQ, Roth M, Iversen LL 1980 Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett 20: 373.PubMedCrossRefGoogle Scholar
  27. 27.
    Ferrier IN, Cross AJ, Johnson JA, Robert GW, Crow TJ, Corsellis JAN, Lee YC, O’Shaughnessy D, Adrian TE, McGregor GP, BaraceseHamilton AJ, Bloom SR 1983 Neuropeptides in Alzheimer type dementia. J Neurol Sci 62: 159.PubMedCrossRefGoogle Scholar
  28. 28.
    Gusella JF, Wexfler N, Conneally PM, Naylor PL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi AY, Young AB, Shoulsow I, Bonilla E, Martin JB 1983 A polymorphic DNA marker genetically linked to Huntington’s disease. Nature 306: 234.PubMedCrossRefGoogle Scholar
  29. 29.
    Marshall PE, Landis DMD, Williams RS 1983 Fibers containing somatostatin-like immunoreactivity increase in the neostriatum in Huntington’s disease. Neurology 33: 159.Google Scholar
  30. 30.
    Corkin S, Davies KL, Growdow JH, Usdin E, Wurtman RJ 1984 Aging. Alzheimer’s Disease: A Report of Progress in Research. Raven Press, New York, vol. 19.Google Scholar
  31. 31.
    Mesulam MM, Myfson EJ, Levey AI, Wainer BH 1983 Cholinergic innervation of cortex by the basal forebrain; cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkey. J Comp Neurol 214: 170.PubMedCrossRefGoogle Scholar
  32. 32.
    Armstrong DM, Saper CB, Levei AI, Wainer BH, Terry RD 1983 Distribution of cholinergic neurons in rat brain demonstrated by the immunocytochemical localization of choline acetyltransferase. J Comp Neurol 216: 53.PubMedCrossRefGoogle Scholar
  33. 33.
    McKinney M, Coyle JT, Hedreen JC 1983 Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol 217: 103.PubMedCrossRefGoogle Scholar
  34. 34.
    Rossor MN, Emson PC, Iversen LL, Mountjoy CD, Roth M, Fahrenkrug J, Rehfeld JF 1982 Neuropeptides and neurotransmitters in cerebral cortex in Alzheimer’s disease. In: Corkin S, Davies KL, Growdow JH, Usdin E, Wurtman RJ (eds) Aging. Alzheimer’s Disease: a Report of Progress in Research. Raven Press, New York, 19: 15.Google Scholar
  35. 35.
    Rossor MN, Emson PC, Iversen LI, Mountjoy CQ, Roth M 1984 Patterns of neuropeptide deficits in Alzheimer’s disease. In: Wurtman RJ, Corkin SH, Growdow JH (eds) Alzheimer’s Disease: Advances in Basic Research and Therapies. Center for Brain Sciences and Metabolism, Charitable Trust, p 29.Google Scholar
  36. 36.
    Davies P, Katz DA, Crystal HA 1982 Choline acetyl transferase, somatostatin and substance P in selected cases of Alzheimer’s disease. In: Corkin S, Davies KL, Growdow JH, Usdin E, Wurtman RJ (eds) Aging. Alzheimer’s Disease: A Report of Progress in Research. Raven Press, New York, 15: 9.Google Scholar
  37. 37.
    Boller F, Mizutani T, Roesman U, Gambetti P 1980 Parkinson disease, dementia and Alzheimer disease: clinicopathological correlations. Ann Neurol 7: 329.PubMedCrossRefGoogle Scholar
  38. 38.
    Hakim AM, Mathieson G 1979 Dementia in Parkinson’s disease: a neuropathologic study. Neurology 29: 1209.PubMedCrossRefGoogle Scholar
  39. 39.
    Dubois B, Ruberg M, Javoy Agid F, Agid Y 1983 A subcorticocortical cholinergic system is affected in Parkinson’s disease. Brain Res 288: 213.PubMedCrossRefGoogle Scholar
  40. 40.
    Ruberg M, Ploska A, Javoy-Agid F, Agid Y 1982 Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia. Brain Res 232: 129.PubMedCrossRefGoogle Scholar
  41. 41.
    Rorstad OP, Epelbaum J, Brazeau P, Martin JB 1979 Chromatographic and biological properties of immunoreactive somatostatin in hypothalamic and extrahypothalamic brain regions of the rat. Endocrinology 105: 1083.PubMedCrossRefGoogle Scholar
  42. 42.
    Wood PL, Etienne P, Lal S, Nair NPV, Bird MD 1983 A post mortem comparison of the cortical cholinergic system in Alzheimer’s disease and Pick’s disease. J Neurol Sci 62: 211.PubMedCrossRefGoogle Scholar
  43. 43.
    Morrison JH, Benoit R, Magistretti PJ, Bloom FE 1983 Immunohistochemical distribution of pro-somatostatin-related peptides in cerebral cortex. Brain Res 262: 344.PubMedCrossRefGoogle Scholar
  44. 44.
    Sorensen KV 1982 Somatostatin: localization and distribution in the cortex and the subcortical white matter of human brain. Neuroscience 7: 1227.PubMedCrossRefGoogle Scholar
  45. 45.
    McKinney M, Davies P, Coyle JT 1982 Somatostatin is not colocalized in cholinergic neurons innervating the rat cerebral cortex-hippocampal formation. Brain Res 243: 169.PubMedCrossRefGoogle Scholar
  46. 46.
    Eckenstein F, Thoenen H 1983 Cholinergic neurons in the rat cerebral cortex demonstrated by immunohistochemical localization of choline acetyltransferase. Neurosci Lett 36: 211.PubMedCrossRefGoogle Scholar
  47. 47.
    Houser CR, Crawford GD, Barber RP, Salvaterra PM, Vaughn JE 1983 Organization and morphological characteristics of cholinergic neurons: an immunocytochemical study with a monoclonal antibody to choline acetyltransferase. Brain Res 266: 97.PubMedCrossRefGoogle Scholar
  48. 48.
    Delfs JR, Zhu CH, Dichter MA 1984 Coexistence of acetylcholine-esterase and somatostatin immunoreactivity in neurons cultured from rat cerebrum. Science 223: 61.PubMedCrossRefGoogle Scholar
  49. 49.
    Zigmond RE, Ben Ari Y 1976 A simple method for the serial sectioning of fresh brains and removal of identifiable nuclei from stained sections for biochemical analysis. J Neurochem 26: 1279.PubMedCrossRefGoogle Scholar
  50. 50.
    Fibiger HC 1982 The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res Rev 4: 327.CrossRefGoogle Scholar
  51. 51.
    Lamour Y, Dutar P, Jobert A 1982 Excitating effect of acetylcholine on different types of neurons in the first somatosensory neocortex of the rat laminar distribution and pharmacological characteristics. Neuroscience 7: 1483.PubMedCrossRefGoogle Scholar
  52. 52.
    Lamour Y, Dutar P, Jobert A 1983 A comparative study of two populations of acetylcholine sensitive neurons in rat somatosensory cortex. Brain Res 289: 157.PubMedCrossRefGoogle Scholar
  53. 53.
    Robbins RJ, Sutton RE, Reichlin S 1982 Effects of neurotransmitters and cyclic AMP on somatostatin release from cultured cerebral cortical cells. Brain Res 234: 377.PubMedCrossRefGoogle Scholar
  54. 54.
    Nemeth EF, Cooper JR 1979 Effect of somatostatin on acetylcholine release from rat hippocampal synaptosomes. Brain Res 165: 166.PubMedCrossRefGoogle Scholar
  55. 55.
    Malthe-Sorensen D, Wood PL, Cheney DL, Costa E 1978 Modulation of the turnover rate of acetylcholine in rat brain by intra-ventricular injections of thyrotropin releasing hormone, somatostatin, neurotensin and angiotensin II. J Neurochem 31: 685.CrossRefGoogle Scholar
  56. 56.
    Wood PL, Cheney DL, Costa E 1979 Modulation of the turnover rate of hippocampal acetylcholine by neuropeptides; possible site of action of alpha-melanocyte stimulating hormone adrenocorticotrophic hormone and somatostatin. J Pharm Exp Ther 209: 97.Google Scholar
  57. 57.
    Czernik AJ, Petrack B 1983 Somatostatin receptor binding in rat cerebral cortex. J Biol Chem 258: 5525.PubMedGoogle Scholar
  58. 58.
    Epelbaum J, Ruberg M, Moyse E, Agid FJ, Dubois B, Agid Y 1983 Somatostatin and dementia in Parkinson’s disease. Brain Res 278: 376.PubMedCrossRefGoogle Scholar
  59. 59.
    Epelbaum J, Agid Y, Dubois B, Enjalbert A, Javoy F, Moyse E, Ruberg M, Somatostatin levels and binding sites in the cortex of parkinsonian subjects: relationships with dementia. Program of the Meeting on Peptides and Neurological Diseases, Cambridge 1983 ( Abstract).Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • J. Epelbaum
    • 1
  • Y. Agid
    • 3
  • A. Enjalbert
    • 1
  • M. Hamon
    • 2
  • F. Javoy-Agid
    • 3
  • C. Kordon
    • 1
  • Y. Lamour
    • 1
  • E. Moyse
    • 1
  1. 1.Unités 159ParisFrance
  2. 2.114, 161 INSERMParisFrance
  3. 3.Laboratoire de Médecine Expérimentale de la PitiéParisFrance

Personalised recommendations